Articles from Soleo Health

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it achieved accreditations from the Accreditation Commission for Health Care (ACHC) for four pharmacy services: Specialty Pharmacy, with a Distinction in Rare Diseases and Orphan Drugs, Ambulatory Infusion Centers, Home Infusion Therapy and Infusion Pharmacy.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the opening of its ambulatory infusion suite (AIS) in Fort Wayne, further expanding its presence in the Indiana marketplace.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been named the exclusive in-network specialty pharmacy for Qfitlia™ (fitusiran) by Sanofi, an innovative global healthcare company. Soleo Health will be the specialty pharmacy to dispense Qfitlia, the first antithrombin-lowering therapy for hemophilia.* The US Food and Drug Administration has recently approved its use for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients (aged 12 or older) with hemophilia A or B with or without factor VIII or IX inhibitors.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it earned its Specialty Pharmacy Accreditation from URAC.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the opening of its new ambulatory infusion suite (AIS) in the metro Denver area, complementing its existing specialty home infusion service offering. Soleo Health operates a specialty pharmacy nearby in Centennial, CO.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it is further extending care in Tennessee with the opening of an ambulatory infusion suite (AIS) in Farragut, Tennessee, just outside of Knoxville.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the appointment of Jason Weems to the newly created Chief Information Officer (CIO) position.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been named a limited distribution specialty pharmacy partner for GC Biopharma USA, Inc. to dispense ALYGLOTM (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI).

Soleo Health, a national provider of complex specialty pharmacy services, announced today the opening of its latest pharmacy and ambulatory infusion center (AIC) in Ridgeland, Mississippi.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services for treating rare- and ultra-rare diseases, announced today it has been named a limited distribution specialty pharmacy partner to dispense RYPLAZIM® (plasminogen, human-tvmh), manufactured by Kedrion Biopharma.

Soleo Health, a national leader in complex specialty pharmacy services, recently marked its 10th anniversary on February 24, 2024.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it ranked 16th on Dallas Business Journal’s ninth annual list of the 50 Fastest-Growing Middle Market Companies throughout the Dallas-Fort Worth area.

Soleo Health, an innovative, leading national provider of complex specialty pharmacy services, announced today the opening of its Boise, Idaho, pharmacy and infusion center location.

Soleo Health, an innovative, leading national provider of complex specialty pharmacy services, announced today the unveiling of its Blue Ash, Ohio location in the greater Cincinnati area.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the appointment of Susan Faust to the newly created role of chief strategy officer.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the Company is prepared to address anticipated increases in demand from Alzheimer’s Disease patients prescribed LEQEMBI™ (lecanemab-irmb) on the heels of the drug receiving full Food & Drug Administration (FDA) approval today.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been selected by Eisai Inc., a developer of pharmaceuticals, as the sole specialty pharmacy distribution partner for newly U.S. Food & Drug Administration (FDA)-approved LEQEMBI™ (lecanemab-irmb) for the treatment of Alzheimer’s Disease (AD). LEQEMBI, an anti-amyloid monoclonal antibody used to treat mild cognitive impairment (MCI) due to AD and mild AD (collectively known as early AD), was approved by the FDA on January 6, 2023.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the appointment of Chief Executive Officer Drew Walk to the National Home Infusion Association (NHIA) 2023-2024 Board of Directors.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been awarded three accreditations from The Joint Commission, a global driver of quality improvement and patient safety in healthcare. The Joint Commission seeks to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating health care organizations and inspiring them to excel in providing safe and effective care of the highest quality and value.

Please replace the release with the following corrected version due to multiple revisions updating the number of accreditations.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it ranked eighth on Dallas Business Journal’s eighth annual list of the 50 Fastest-Growing Middle Market Companies across the Dallas-Fort Worth area. This marks the Company’s fifth consecutive year appearing in the list of top 10 fastest growing companies in North Texas, one of the country’s largest metropolitan growth areas and highly competitive marketplaces in the U.S.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has added AMVUTTRA™ (vutrisiran) to its specialty pharmacy portfolio to treat adults with the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis.

Headline of release dated July 26, 2022, should read: Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO®

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it was named one of only four limited distribution drug (LDD) specialty pharmacy partners to dispense nationwide RADICAVA ORS® (edaravone) oral suspension, commercialized by Mitsubishi Tanabe Pharma America, Inc. (MTPA), which commercializes approved pharmaceutical products in North America.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been named a limited distribution drug partner for ENSPRYNG® (satralizumab-mwge), manufactured by Genentech, a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with severe and life-threatening diseases.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it was named the winner of four Gold Stevie® Awards and one Silver in The 20th Annual American Business Awards® (ABA).

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it earned Specialty Pharmacy Accreditation from URAC. URAC is an independent leader in promoting health care quality by setting high standards for clinical practice, consumer protections, performance measurement, operations infrastructure and risk management. By achieving this status, Soleo Health continues to demonstrate its commitment to quality care, enhanced processes, patient safety and improved outcomes.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it is urging Centers for Medicare & Medicaid Services (CMS), US Department of Health & Human Services to allow patient access to monoclonal antibodies directed against Amyloid for the treatment of Alzheimer’s Disease.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it achieved accreditation through the Accreditation Commission for Health Care (ACHC) as a specialty pharmacy with distinction in rare disease and orphan drugs. The Company is one in only six nationally to earn this prestigious ACHC distinction.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it was selected as a limited distribution partner for VYVGART™ (efgartigimod alfa-fcab) by argenx SE. VYVGART was approved by the U.S. Food & Drug Administration (FDA) on December 17, 2021 for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has access to OXLUMO™ (lumasiran), managed by Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company. This access allows Soleo Health to administer OXLUMO to lower patients' urinary oxalate levels in children and adults with primary hyperoxaluria type 1 (PH1), an ultra-rare genetic disorder.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today its Philadelphia location has earned Specialty Pharmacy Accreditation from URAC, the leading independent accrediting organization focused on supporting the quality of health care through leadership, accreditation, measurement and innovation standards and programs.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the unveiling of its Thyroid Eye Disease (TED) Therapeutic Care Management Center (TCMC), dedicated to caring for and treating patients with thyroid eye disease, a rare ophthalmic, vision-threatening condition.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it ranked ninth on the Dallas Business Journal’s seventh annual list of the 50 Fastest-growing Middle Market Companies in the Dallas-Fort Worth area.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy and infusion services, announced today its strong support of the introduction of S.2652, The Preserving Patient Access to Home Infusion Act by U.S. Senators Mark Warner (D-VA) and Tim Scott (R-SC). This legislation would ensure patients’ access to life-saving home infusion therapy by providing appropriate reimbursement for such professional services.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it was selected by Houston Methodist to provide monoclonal antibody therapy (mAb) to COVID-19 patients in their homes. Monoclonal antibody treatment is the most effective first-line therapy for otherwise hospital-bound patients. The hospital system is among the nation’s largest providers of mAb therapy and has a partnership with the U.S. Department of Human Services, supported by KPMG LLP, to expand access to COVID-19 monoclonal antibody treatment to underserved and disadvantaged patients in the greater Houston area.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy and infusion services, announced today the appointment of Becky Rand to the post of vice president business development, industry relations.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy and infusion services, announced today its Phoenix, Arizona location has earned Specialty Pharmacy Accreditation from URAC, the leading independent accrediting organization focused on supporting the quality of health care through leadership, accreditation, measurement and innovation standards and programs.